Suicidality and divalproex sodium: analysis of controlled studies in multiple indications
Open Access
- 1 January 2011
- journal article
- Published by Springer Nature in Annals of General Psychiatry
- Vol. 10 (1) , 1
Abstract
Recent analyses of antiepileptic drugs have indicated an increase in the risk of suicidality. The objective of this report was to provide clinical information and an independent meta-analysis of divalproex sodium and suicidality events by analyzing data from 13 placebo-controlled studies and 1 low-dose controlled study.Keywords
This publication has 36 references indexed in Scilit:
- A Randomized, Placebo-Controlled, Multicenter Study of Divalproex Sodium Extended-Release in the Acute Treatment of ManiaThe Journal of Clinical Psychiatry, 2010
- SUICIDALITY, DEPRESSION SCREENING, AND ANTIEPILEPTIC DRUGS: REACTION TO THE FDA ALERTNeurology, 2009
- Mental disorders, comorbidity and suicidal behavior: Results from the National Comorbidity Survey ReplicationMolecular Psychiatry, 2009
- Don’t be afraid to treat depression in patients with epilepsy!Acta Neurologica Scandinavica, 2009
- Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: A review of the evidenceJournal of Affective Disorders, 2009
- Suicide in Patients with EpilepsyEpilepsy Currents, 2008
- Psychiatric Comorbidity in Epilepsy: A Population‐Based AnalysisEpilepsia, 2007
- The Personal and Financial Impact of Repetitive or Prolonged Seizures on the Patient and FamilyJournal of Child Neurology, 2007
- Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 yearsBipolar Disorders, 2006
- Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality DisordersNeuropsychopharmacology, 2003